drugset / Trial / NCT00928278

A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

NCT00928278

Phase 1 Completed 36 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to investigate the time course of PF-04764793 concentration in the blood following dosing by oral inhalation from dry powder inhalers.

Timeline

Start
2009-07
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04764793 Unknown 150 unknown Inhaled
Subject PF-04764793 Unknown 300 unknown Inhaled
Background Activated Charcoal Other / unclassified Oral

Indications

No indication recorded.